期刊文献+

肺动脉灌注低温肺保护液对合并重度肺高压先天性心脏病患儿的肺保护效果评价 被引量:1

The Effect of Pulmonary Artery Perfusion with Hypothermic Lung-protective Solution to Congenital Heart Disease Patients with Pulmonary Hypertension
暂未订购
导出
摘要 目的评价体外循环期间肺动脉灌注低温保护液对合并重度肺高压先天性心脏病患儿的肺保护作用。方法将20例合并重度肺高压先天性心脏病患儿随机分为对照组和实验组。实验组在主动脉阻断后经肺动脉灌注低温保护液,对照组则不灌注肺保护液。不同时间点采集外周动脉血,进行中性粒细胞计数,不同时间点检测动脉血氧分压、吸入氧浓度、气道阻力,计算氧指数。结果对照组在升主动脉开放20min中性粒细胞计数较术前明显降低,实验组的中性粒细胞计数在体外循环结束时明显高于术前,实验组与对照组的氧指数在体外循环结束后6h达到最低点,实验组的氧指数在体外循环结束后12h回升接近术前正常水平,而对照组则未回升至术前正常水平。在体外循环结束后0、3、6、12h,实验组的氧指数均明显高于对照组。结论体外循环后存在肺损伤,使用低温肺动脉灌注液可明显减轻合并重度肺高压先天性心脏病患儿的这种肺损伤。 Objective The aim was to determine the effect of pulmonary peffusion with hypothermie protective solution on lung function during eardiopulmonary bypass (CPB) .Methods Twenty congenital heart disease patients with pulmonary hypertension were randomly divided into two groups. During CPB, the study group were perfused with 4℃ protective solution, control group were not. Neutrophil counts and PaO2/FiO2 ratio were measured at different time-points. Results In study group, the Neutroplfil counts at the termination of CPB were lower than the prebypass value. In control group, the Neutrophil counts at the 10 vain after removal of aortic cross-clamp were lower than the prebypass value. At each measuring point PaO2/FiO2 ratio of the study group was significantly lfigher fir.an that of the control group ( P 〈 0.05) .The PEA.a]O2 Values of study group were significantly lower than those of control group ( P 〈 0. 001 ) after CPB. The P[A-a]O2 Values of study group after CPB wre no differencr from those before CPB. Conclusion Tiffs study de.monstrated that pulmonary artery peffusion with the hypothermic protective solution can obviously reduce lung injury after eardiopul- monary bypass.
出处 《中国实验诊断学》 2008年第5期616-619,共4页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技厅科技发展计划基金资助(200505157)
关键词 抑肽酶 沐舒坦 肺动脉灌注 肺保护液 体外循环 Pulmonary artery Peffusion Cardiopulmonary bypass lung injury
  • 相关文献

参考文献9

  • 1Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions [ J ]. Ann Intern Med, 1983,98: 593.
  • 2Messent M, Sullivan K, Keogh BF, et al. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction[J]. Anaesthesia, 1992,47 : 267.
  • 3Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post- pump syndrome[J]. Ann Thorac Surg, 1999,67:978.
  • 4Wan S, LeClere JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies [ J ]. Chest, 1997,112 : 676.
  • 5Tanita T, Song C, Kubo H, et al. Superoxide anion mediates pulmonary vascular permeability, caused by neutrophils in cardiopulmonary bypass [J]. Surg Today, 1999,29:755.
  • 6Gu Y J, Boonstra PW, Graaff R, et al. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonay bypass: a cornparison between hollow fiber and flat sheet membrane oxygenators[ J ]. Artif Organs,2000, 24:43.
  • 7Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies [ J ]. Chest, 1997, 112: 676.
  • 8Carney DE, Lutz CJ, Picone AL, et al, Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass[J]. Circulation, 1999,100:400.
  • 9Blackstone EH, Kirklin JW, Stewart RW, et al. The damaging effects of cardiopulmonary bypass. In: KK Wu, EC Rossi, eds. Prostagtandins in clinical medicine: cardiovascular and thrombotic disorders[ M]. Chicago: Year Book Medical, 1982:355.

同被引文献18

  • 1庞昕焱,李卫华,宋惠民,苏润毅,于建华,李跃华,毕研文,李守先.单向活瓣补片在合并重度肺动脉高压的先天性心脏病患者手术治疗中的应用[J].中华医学杂志,2004,84(11):888-890. 被引量:30
  • 2李少民,王丽娜,张莉,李二田,万俊哲.先天性心脏病合并重度肺动脉高压的诊断及外科治疗[J].中国胸心血管外科临床杂志,2006,13(6):434-436. 被引量:18
  • 3杨再珍,范书润,冯光强,邢志嵩,王攀,杨栋.室缺肺高压手术的疗效观察[J].医药论坛杂志,2007,28(6):4-6. 被引量:1
  • 4Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease[ J]. Chest,2010,137 (6) :52.
  • 5Gatzoulis MA, Alonso - Gonzalez R, Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease[J]. Eur Respir Rev,2009,18(113) :154.
  • 6Peter JB, Raed AD, Arthur FG, et al. Exhaled nitric oxide in pulmonary diseases : A Comprehensive Review [ J ]. Chest ,2010,138:682.
  • 7Scott DH, Darren BT. Misclassifieation of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end diastolic pressure [ J ]. Chest,2009,136 : 37.
  • 8Susan H, Helen W, Catriona M. Failure of medical therapy in pulmonary arterial hypertension : ls there an alternative diagnosis [ J ]. Chest,2009, 135 : 1462.
  • 9David BB ,Steven HA, Gerald S,et al. Medical Therapy for Pulmonary Arterial Hypertension:Updated ACCP Evidence - Based Clinical Practice Guidelines[ J]. Chest ,2007,131 : 1917.
  • 10DAlto M, Romeo E, Argiento P,et al. Pulmonary vasoreactivity predicts long term outcome in patients with Eisenmenger syndrome receiving bosentan therapy [ J]. Heart, 2010,96 ( 18 ) : 1475.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部